Addition of aldosterone receptor blocker to dual renin-angiotensin-aldosterone blockade leads to limitation of tubulointerstitial injury of kidney

Kidney Int. 2007 Nov;72(9):1164-5. doi: 10.1038/sj.ki.5002511.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial
  • Comment

MeSH terms

  • Angiotensin II Type 1 Receptor Blockers / therapeutic use*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Benzimidazoles / therapeutic use
  • Benzoates / therapeutic use
  • Cilazapril / therapeutic use
  • Cross-Over Studies
  • Drug Therapy, Combination
  • Humans
  • Mineralocorticoid Receptor Antagonists / therapeutic use*
  • Nephritis, Interstitial / drug therapy*
  • Renin-Angiotensin System / drug effects
  • Spironolactone / therapeutic use
  • Telmisartan

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Benzimidazoles
  • Benzoates
  • Mineralocorticoid Receptor Antagonists
  • Cilazapril
  • Spironolactone
  • Telmisartan